ACLY inhibitors (Nimbus Therapeutics/Columbia University)

N/A

Report date: 2025/03/18 18:07:33
NME

Base Information

Drug NameACLY inhibitors (Nimbus Therapeutics/Columbia University)
Drug Alias NameATP-citrate lyase inhibitors (Nimbus Therapeutics/Columbia University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATP-citrate synthase inhibitors
TargetsATP-citrate synthase
Therapy Area/IndicationsMetabolic DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesColumbia University
China Registration ClassN/A

Develop Information

Active CompaniesNimbus Therapeutics LLCColumbia University
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A